|
22 May 2007 |
Nektar Therapeutics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
|
|
22 May 2007 |
Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
|
|
22 May 2007 |
Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
|
|
22 May 2007 |
Additional Satraplatin Efficacy Data From Phase 3 SPARC Trial Presented at Annual Meeting of American Urological Association
|
|
22 May 2007 |
Amlodipine and Olmesartan Study Results Released;
|
|
19 May 2007 |
FDA Approves Lovenox (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
|
|
19 May 2007 |
Basilea Announces the Submission to U.S. Authorities of a New Drug Application for Ceftobiprole, a Novel anti-MRSA Broad-spectrum Cephalosporin
|
|
18 May 2007 |
FDA Approves AstraZeneca’s Once-Daily SEROQUEL XR(TM) Extended-Release Tablets For The Treatment Of Schizophrenia
|
|
17 May 2007 |
Trophos Starts Phase II Clinical Trial of TRO19622 in Painful Diabetic Neuropathy
|
|
17 May 2007 |
BioLineRx Initiates a Clinical Receptor-Occupancy Study of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia
|
|
17 May 2007 |
Pivotal phase IIIa trials for Organon's novel oral contraceptive, NOMAC/E2, complete recruitment
|
|
17 May 2007 |
InterMune Completes Patient Enrollment in Phase 3 'Capacity' Program Evaluating Pirfenidone in Patients With IPF
|
|
17 May 2007 |
Obecure Initiates Phase II Study to Examine Effect of OBE101 on Plasma Lipids in Patients Treated With Simvastatin
|
|
17 May 2007 |
CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
|
|
17 May 2007 |
Can-Fite to Commence Phase II Clinical Trials to Investigate the Efficacy of CF101 in the Treatment of Psoriasis
|
|
17 May 2007 |
Danube Pharmaceuticals Initiates a Multi-Center Phase II Clinical Trial of DNB-001 in Patients with Ocular Hypertension
|
|
17 May 2007 |
MethylGene Selects Histone Deacetylase Antifungal Clinical Candidate
|
|
16 May 2007 |
Positive Statistical Analysis from Synthetic Blood's Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
|
|
16 May 2007 |
SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
|
|
15 May 2007 |
Wyeth and Progenics Pharmaceuticals Announce Submission of Marketing Application in Europe for the Subcutaneous Formulation of Methylnaltrexone
|
|
15 May 2007 |
Luitpold Pharmaceuticals, Inc., Announces NDA Submission for Injectafer (Ferric Carboxymaltose Injection), a Next Generation Intravenous Iron Product
|
|
15 May 2007 |
Momenta Pharmaceuticals Initiates Phase I Clinical Study for M118 Subcutaneous Formulation
|
|
15 May 2007 |
Critical Therapeutics' Sales Force Gains Access to a Second Product as FDA Approves Co-Promotion Partner's New Treatment for COPD
|
|
15 May 2007 |
Skyepharma PLC and Sciele Pharma Announce Successful Completion of New Sular(R) Formulation Clinical Trial Programme
|
|
15 May 2007 |
Avicena Initiates Phase I Clinical Trial in Amyotrophic Lateral Sclerosis (ALS)
|
